Oncology Institute Inc reports results for the quarter ended in June - Earnings Summary

Oncology Institute

13/08/2024 22:01

* Oncology Institute Inc  TOI.OQ  reported a quarterly
adjusted
loss of 17 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -19 cents.  The lone analyst forecast for the
quarter was for a loss of 10 cents per share. 
    * Revenue rose 22.9% to $98.58 million from a year ago;
analysts
expected $103.31 million. 
    * Oncology Institute Inc's reported EPS for the quarter was
a loss
of 17 cents​.
    * The company reported a quarterly loss of $15.48 million.
    * Oncology Institute Inc shares had risen by 5.4% this
quarter and
lost 76.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "strong buy"

Wall Street's median 12-month price target for Oncology
Institute Inc is $2.00 
This summary was machine generated from LSEG data August 13 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024                     -0.17          
 Mar. 31 2024      -0.12          -0.22          Missed
 Dec. 31 2023      -0.11          -0.21          Missed
 Sep. 30 2023      -0.13          -0.19          Missed